PhaseBio Pharmaceuticals Market Cap

PhaseBio Pharmaceuticals has a market cap or net worth of $49.00 as of April 25, 2024. Its market cap has decreased by -100.00% in one year.

Market Cap

49.00

Enterprise Value

-2.43M

1-Year Change

-100.00%

Ranking

n/a

Market Cap Chart

Since October 18, 2018, PhaseBio Pharmaceuticals's market cap has decreased from $97.90M to $49.00, a decrease of -100.00%. That is a compound annual growth rate of -97.23%.

Market Cap History

Date	Market Cap	% Change
Nov 2, 2022	3.50M	-25.53%
Nov 1, 2022	4.70M	-7.84%
Oct 31, 2022	5.10M	-3.77%
Oct 28, 2022	5.30M	-19.70%
Oct 27, 2022	6.60M	8.20%
Oct 26, 2022	6.10M	-8.96%
Oct 25, 2022	6.70M	-4.29%
Oct 24, 2022	7.00M	-29.29%
Oct 21, 2022	9.90M	-
Oct 20, 2022	9.90M	4.21%
Oct 19, 2022	9.50M	-2.06%
Oct 18, 2022	9.70M	-1.02%
Oct 17, 2022	9.80M	-5.77%
Oct 14, 2022	10.40M	4.00%
Oct 13, 2022	10.00M	5.26%
Oct 12, 2022	9.50M	5.56%
Oct 11, 2022	9.00M	-1.10%
Oct 10, 2022	9.10M	-
Oct 7, 2022	9.10M	-5.21%
Oct 6, 2022	9.60M	5.49%
Oct 5, 2022	9.10M	-3.19%
Oct 4, 2022	9.40M	4.44%
Oct 3, 2022	9.00M	2.27%
Sep 30, 2022	8.80M	-7.37%
Sep 29, 2022	9.50M	-25.78%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	695.32B
Novo Nordisk	564.00B
UnitedHealth Group	452.88B
Johnson & Johnson	359.35B
Merck & Co.	321.49B
AbbVie	297.27B
AstraZeneca	217.39B
Thermo Fisher	209.32B

Market Cap Rankings